• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Omeros Corp (NQ: OMER )

    4.590 +0.040 (+0.88%)
    Streaming Delayed Price Updated: 12:09 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Omeros Corp

    < Previous 1 2 3 4 5 6 7 8 Next >
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Omeros Announces Webcast Details for Annual Meeting of Shareholders
    From Omeros Corporation
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022
    Upgrades 
    Via Benzinga
    Earnings Scheduled For March 1, 2022
    Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Monday's session saw 84 companies set new 52-week lows. 
    Via Benzinga
    Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)
    Via AB Newswire
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 73 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    During Friday's session, 59 stocks hit new 52-week lows. 
    Via Benzinga
    90 Biggest Movers From Yesterday
    Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
    Via Benzinga
    58 Stocks Moving In Thursday's Mid-Day Session
    Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
    Via Benzinga
    Omeros: Q1 Earnings Insights
    Omeros (NASDAQ:OMER) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros beat estimated earnings by 25.35%,... 
    Via Benzinga
    Omeros Corporation Reports First Quarter 2022 Financial Results
    From Omeros Corporation
    Via Business Wire
    52 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247... 
    Via Benzinga
    Omeros Earnings Preview
    Omeros (NASDAQ:OMER) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Omeros will report an... 
    Via Benzinga
    Omeros Corporation to Announce First Quarter Financial Results on May 10, 2022
    From Omeros Corporation
    Via Business Wire
    Earnings Scheduled For May 10, 2022
    Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    On Thursday, 236 companies hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
    Via Benzinga
    Omeros Announces Journal of Clinical Oncology Publication Detailing Pivotal Trial Results for Narsoplimab in HSCT-TMA
    From Omeros Corporation
    Via Business Wire
    Stocks That Hit 52-Week Lows On Tuesday
    On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million. 
    Via Benzinga
    Omeros's Return On Capital Employed Insights
    According to Benzinga Pro, during Q4, Omeros (NASDAQ:OMER) earned $280.62 million, a 1336.05% increase from the preceding quarter. Omeros also posted a total of $30.84 million in... 
    Via Benzinga
    Omeros: Q4 Earnings Insights
    Omeros (NASDAQ:OMER) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros missed... 
    Via Benzinga
    Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 1, 2022
    From Omeros Corporation
    Via Business Wire
    The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In... 
    Via Benzinga
    Omeros Submits Response To FDA Regarding Narsoplimab Application In HSCT-TMA
    Omeros Corporation (NASDAQ: OMER) has submitted to the FDA its response to Complete Response Letter for narsoplimab in hematopoietic stem cell transplant-associated... 
    Via Benzinga
    Omeros Confirms Submission of Response to FDA Regarding the BLA for Narsoplimab in the Treatment of HSCT-TMA
    From Omeros Corporation
    Via Business Wire
    Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical
    From Omeros Corporation
    Via Business Wire
    Omeros Corporation (NASDAQ:OMER) Investor Notice: Investigation over Potential Wrongdoing
    San Diego, CA -- (SBWIRE) -- 12/14/2021 -- Certain directors of Omeros Corporation are under investigation over potential breaches of fiduciary duties. 
    Via SBWire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.